Seeding variability of different alpha synuclein strains in synucleinopathies
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Objectives: Currently, the exact reasons why different α‐synucleinopathies exhibit variable pathologies and phenotypes are still unknown. A potential explanation may be the existence of distinctive α‐synuclein conformers or strains. Here, we intend to analyze the seeding activity of dementia with Lewy bodies (DLB) and Parkinson's disease (PD) brain‐derived α‐synuclein seeds by real‐time quaking‐induced conversion (RT‐QuIC) and to investigate the structure and morphology of the α‐synuclein aggregates generated by RT‐QuIC. Methods: A misfolded α‐synuclein–enriched brain fraction from frontal cortex and substantia nigra pars compacta tissue, isolated by several filtration and centrifugation steps, was subjected to α‐synuclein/RT‐QuIC analysis. Our study included neuropathologically well‐characterized cases with DLB, PD, and controls (Ctrl). Biochemical and morphological analyses of RT‐QuIC products were conducted by western blot, dot blot analysis, Raman spectroscopy, atomic force microscopy, and transmission electron microscopy. Results: Independently from the brain region, we observed different seeding kinetics of α‐synuclein in the RT‐QuIC in patients with DLB compared to PD and Ctrl. Biochemical characterization of the RT‐QuIC product indicated the generation of a proteinase K–resistant and fibrillary α‐synuclein species in DLB‐seeded reactions, whereas PD and control seeds failed in the conversion of wild‐type α‐synuclein substrate. Interpretation: Structural variances of α‐synuclein seeding kinetics and products in DLB and PD indicated, for the first time, the existence of different α‐synuclein strains in these groups. Therefore, our study contributes to a better understanding of the clinical heterogeneity among α‐synucleinopathies, offers an opportunity for a specific diagnosis, and opens new avenues for the future development of strain‐specific therapies. Ann Neurol 2019;85:691–703
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van den Haute, C., Melki, R., & Baekelandt, V. (2015) · Nature · doi:10.1038/nature14547 · Cited by 1,130
Papp, M. I., Kahn, J. E., & Lantos, P. L. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90219-0 · Cited by 991
Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
Guo, J. L., Covell, D. J., Daniels, J. P., Iba, M., Stieber, A., Zhang, B., Riddle, D. M., Kwong, L. K., Xu, Y., Trojanowski, J. Q., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.057 · Cited by 680
Alpha‐synuclein RT ‐Qu IC in the CSF of patients with alpha‐synucleinopathies
Fairfoul, G., McGuire, L. I., Pal, S., Ironside, J. W., Neumann, J., Christie, S., Joachim, C., Esiri, M., Evetts, S. G., Rolinski, M., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.338 · Cited by 608
Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies
Peng, C., Gathagan, R. J., Covell, D. J., Medellin, C., Stieber, A., Robinson, J. L., Zhang, B., Pitkin, R. M., Olufemi, M. F., Luk, K. C., et al. (2018) · Nature · doi:10.1038/s41586-018-0104-4 · Cited by 605
Braak, H., & Del Tredici, K. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-179001 · Cited by 372 · cited 3×
“We isolated the misfolded α-synuclein–enriched fraction from SNc, a critical region for the progression of PD.(34) Interestingly, α-synuclein seeding activity could be detected in 75% of DLB cases and in 0% in PD and 0% in control cases (Table; Fig 3C,D).”
BackgroundMethodThe prion hypothesis in Parkinson's disease: braak to the future
Visanji, N. P., Brooks, P. L., Hazrati, L.-N., & Lang, A. E. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-2 · Cited by 278
Cited by
Parkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,371
Structures of α-synuclein filaments from human brains with Lewy pathology
Yang, Y., Shi, Y., Schweighauser, M., Zhang, X., Kotecha, A., Murzin, A. G., Garringer, H. J., Cullinane, P. W., Saito, Y., Foroud, T., et al. (2022) · Nature · doi:10.1038/s41586-022-05319-3 · Cited by 475
Rossi, M., Candelise, N., Baiardi, S., Capellari, S., Giannini, G., Orrù, C. D., Antelmi, E., Mammana, A., Hughson, A. G., Calandra-Buonaura, G., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02160-8 · Cited by 451
Self-citationModeling Parkinson’s Disease With the Alpha-Synuclein Protein
Gómez-Benito, M., Granado, N., García-Sanz, P., Michel, A., Dumoulin, M., & Moratalla, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00356 · Cited by 437
Propagative α-synuclein seeds as serum biomarkers for synucleinopathies
Okuzumi, A., Hatano, T., Matsumoto, G., Nojiri, S., Ueno, S.-I., Imamichi-Tatano, Y., Kimura, H., Kakuta, S., Kondo, A., Fukuhara, T., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02358-9 · Cited by 313
Metadata
- Authors
- Candelise, N., Schmitz, M., Llorens, F., Villar‐Piqué, A., Cramm, M., Thom, T., da Silva Correia, S. M., da Cunha, J. E. G., Möbius, W., Outeiro, T. F., Álvarez, V. G., Banchelli, M., D'Andrea, C., de Angelis, M., Zafar, S., Rabano, A., Matteini, P., & Zerr, I.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2019-03-27
- Volume
- 85
- Issue
- 5
- Pages
- 691-703
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2917090762
- Cited by
- 118
- References
- 13
- FWCI
- 10.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Seeding variability of different alpha synuclein strains in synucleinopathies. https://app.cochat.ai/papers/10.1002/ana.25446
- The paper
- Candelise, N., Schmitz, M., Llorens, F., Villar‐Piqué, A., Cramm, M., Thom, T., da Silva Correia, S. M., da Cunha, J. E. G., Möbius, W., Outeiro, T. F., Álvarez, V. G., Banchelli, M., D'Andrea, C., de Angelis, M., Zafar, S., Rabano, A., Matteini, P., & Zerr, I. (2019). Seeding variability of different alpha synuclein strains in synucleinopathies. Annals of Neurology. https://doi.org/10.1002/ana.25446
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.